From: Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study
Univariate (OR [95% CI]) | P | Multivariate (OR [95% CI]) | P | |
---|---|---|---|---|
Malignancy* | 3.86 [1.59, 9.38] | 0.003 | 2.12 [0.73, 6.17] | 0.168 |
Darbepoetin alfa to Hb ratio | 1.15 [1.04, 1.27] | 0.005 | 1.19 [1.07, 1.32] | 0.001 |
Charlson-Age Comorbidity Index | 1.18 [1.04, 1.33] | 0.012 | 1.23 [1.07, 1.40] | 0.003 |
Transferrin saturation | 1.04 [1.01, 1.07] | 0.013 | --- | |
Age 60 and above | 3.34 [1.42, 7.86] | 0.006 | --- | |
Antiepileptic medication | 10.15 [1.10, 93.51] | 0.041 | --- | |
Mean hemoglobin (g/L) | 0.96 [0.93, 1.00] | 0.025 | --- | |
Weekly darbepoetin alfa dose (mcg) | 1.01 [1.00, 1.02] | 0.033 | --- | |
Weekly weight adjusted darbepoetin alfa dose (mcg/kg) | 3.21 [1.29, 7.98] | 0.012 | --- |